Cardiovascular effects of arsenic: Clinical and epidemiological findings

Environmental Science and Pollution Research

Volumn 21, Issue 1, 2014, Pages 244-251

  Stea, Francesco ^a   Bianchi, Fabrizio ^b   Cori, Liliana ^b   Sicari, Rosa ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CNR   (Italy)

Author keywords

Arsenic; Cardiovascular disease; Drinking water; Environmental pollution; Oxidative stress; Toxicology

Indexed keywords

ARSENIC; CARDIOVASCULAR DISEASE; DIABETES; DISEASE INCIDENCE; DRINKING WATER; EPIDEMIOLOGY; HYPERTENSION; MORTALITY; OXIDATION; POLLUTION EXPOSURE; RISK FACTOR; TOXICOLOGY;

ARSENIC;

CARDIOVASCULAR DISEASE; ENVIRONMENTAL EXPOSURE; HUMAN; INCIDENCE; METABOLISM; REVIEW; RISK FACTOR; STATISTICS;

ARSENIC; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84891632028     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-013-2113-z     Document Type: Review

References (85)

1. Abhyankar LN, Jones MR, Guallar E, Navas-Acien A (2012) Arsenic exposure and hypertension: A systematic review. Environ Health Perspect 120(4): 494-500. doi: 10. 1289/ehp. 1103988.
2. Bae ON, Lim KM, Noh JY, Chung SM, Kim SH, Chung JH (2009) Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation. Toxicol Appl Pharmacol 239(2): 144-153. doi: 10. 1016/j. taap. 2008. 12. 020.
3. Balakumar P, Kaur J (2009) Arsenic exposure and cardiovascular disorders: An overview. Cardiovasc Toxicol 9(4): 169-176. doi: 10. 1007/s12012-009-9050-6.
4. Bao L, Shi H (2010a) Arsenite induces endothelial cell permeability increase through a reactive oxygen species-vascular endothelial growth factor pathway. Chem Res Toxicol 23(11): 1726-1734. doi: 10. 1021/tx100191t.
5. Bao L, Shi H (2010b) Potential molecular mechanisms for combined toxicity of arsenic and alcohol. J Inorg Biochem 104(12): 1229-1233. doi: 10. 1016/j. jinorgbio. 2010. 08. 005.
6. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE (1996) Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med 21(6): 783-790.
7. Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M, Roy M (2010) Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Hum Exp Toxicol 29(6): 513-524. doi: 10. 1177/0960327109359020.
8. Brunton LL CB, Knollmann BC (2011) Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th edn. McGraw-Hill.
9. Bunderson M, Brooks DM, Walker DL, Rosenfeld ME, Coffin JD, Beall HD (2004) Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol Appl Pharmacol 201(1): 32-39. doi: 10. 1016/j. taap. 2004. 04. 008.
10. Chang CC, Ho SC, Tsai SS, Yang CY (2004) Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J Toxicol Environ Health A 67(17): 1353-1361. doi: 10. 1080/15287390490471451.
11. Chen Y, Santella RM, Kibriya MG, Wang Q, Kappil M, Verret WJ, Graziano JH, Ahsan H (2007) Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ Health Perspect 115(10): 1415-1420. doi: 10. 1289/ehp. 10277.
12. Chen JW, Chen HY, Li WF, Liou SH, Chen CJ, Wu JH, Wang SL (2011a) The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan. Chemosphere 84(1): 17-24. doi: 10. 1016/j. chemosphere. 2011. 02. 091.
13. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, van Geen A, Ahsan H (2011b) Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 342: d2431.
14. Chen Y, Parvez F, Liu M, Pesola GR, Gamble MV, Slavkovich V, Islam T, Ahmed A, Hasan R, Graziano JH, Ahsan H (2011c) Association between arsenic exposure from drinking water and proteinuria: results from the health effects of arsenic longitudinal study. Int J Epidemiol 40(3): 828-835. doi: 10. 1093/ije/dyr022.
15. Cohen SM, Arnold LL, Eldan M, Lewis AS, Beck BD (2006) Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol 36(2): 99-133.
16. Das NK, Sengupta SR (2008) Arsenicosis: diagnosis and treatment. Indian J Dermatol Venereol Leprol 74(6): 571-581.
17. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10): 1285-1295. doi: 10. 1161/CIRCULATIONAHA. 106. 652859.
18. Del Razo LM, Garcia-Vargas GG, Valenzuela OL, Castellanos EH, Sanchez-Pena LC, Currier JM, Drobna Z, Loomis D, Styblo M (2011) Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ Health 10: 73. doi: 10. 1186/1476-069X-10-73.
19. Delgado-Andrade C, Navarro M, Lopez H, Lopez MC (2003) Determination of total arsenic levels by hydride generation atomic absorption spectrometry in foods from southeast Spain: estimation of daily dietary intake. Food Addit Contam 20(10): 923-932. doi: 10. 1080/02652030310001594450.
20. EFSA-CONTAM (2009) Scientific opinion on arsenic in food EFSA. Journal 7(10): 1351. doi: 10. 2903/j. efsa. 2009. 1351.
21. Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P, Wible BA, Brown AM (2004) Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 66(1): 33-44. doi: 10. 1124/mol. 66. 1. 33.
22. Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51(2): 257-281. doi: 10. 1016/j. freeradbiomed. 2011. 04. 008.
23. Flora SJ, Bhadauria S, Kannan GM, Singh N (2007) Arsenic-induced oxidative stress and the role of antioxidant supplementation during chelation: A review. J Environ Biol 28(2 Suppl): 333-347.
24. Fujiwara Y, Nakase Y, Kaji T (2005) Sodium arsenite inhibits proteoglycan synthesis by vascular endothelial cells in culture. J Health Sci 51(4): 461-468.
25. Ghosh S, Dungdung SR, Chowdhury ST, Mandal AK, Sarkar S, Ghosh D, Das N (2011) Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radic Biol Med 51(10): 1893-1902. doi: 10. 1016/j. freeradbiomed. 2011. 08. 019.
26. Hays AM, Lantz RC, Rodgers LS, Sollome JJ, Vaillancourt RR, Andrew AS, Hamilton JW, Camenisch TD (2008) Arsenic-induced decreases in the vascular matrix. Toxicol Pathol 36(6): 805-817. doi: 10. 1177/0192623308323919.
27. Hinwood AL, Sim MR, Jolley D, de Klerk N, Bastone EB, Gerostamoulos J, Drummer OH (2003) Risk factors for increased urinary inorganic arsenic concentrations from low arsenic concentrations in drinking water. Int J Environ Health Res 13(3): 271-284. doi: 10. 1080/0960312031000122424.
28. Hsieh YC, Lien LM, Chung WT, Hsieh FI, Hsieh PF, Wu MM, Tseng HP, Chiou HY, Chen CJ (2011) Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ Res 111(6): 804-810. doi: 10. 1016/j. envres. 2011. 05. 003.
29. Hsueh YM, Lin P, Chen HW, Shiue HS, Chung CJ, Tsai CT, Huang YK, Chiou HY, Chen CJ (2005) Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension. J Toxicol Environ Health A 68(17-18): 1471-1484. doi: 10. 1080/15287390590967414.
30. Hsueh YM, Chung CJ, Shiue HS, Chen JB, Chiang SS, Yang MH, Tai CW, Su CT (2009) Urinary arsenic species and CKD in a Taiwanese population: A case-control study. Am J Kidney Dis 54(5): 859-870. doi: 10. 1053/j. ajkd. 2009. 06. 016.
31. Huang YL, Hsueh YM, Huang YK, Yip PK, Yang MH, Chen CJ (2009) Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Sci Total Environ 407(8): 2608-2614. doi: 10. 1016/j. scitotenv. 2008. 12. 061.
32. Huang CF, Chen YW, Yang CY, Tsai KS, Yang RS, Liu SH (2011) Arsenic and diabetes: current perspectives. Kaohsiung J Med Sci 27(9): 402-410. doi: 10. 1016/j. kjms. 2011. 05. 008.
33. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ (2011) Arsenic exposure and toxicology: A historical perspective. Toxicol Sci 123(2): 305-332. doi: 10. 1093/toxsci/kfr184.
34. JECFA (1989) Evaluation of certain food additives and contaminants. Thirty-third report of the joint FAO/WHO expert committee on food additives. World Health Organ Tech Rep Ser 776: 1-64.
35. JECFA (2011) Evaluation of certain contaminants in food. World Health Organ Tech Rep Ser 959: 1-105, back cover.
36. Jiang SJ, Lin TM, Wu HL, Han HS, Shi GY (2002) Decrease of fibrinolytic activity in human endothelial cells by arsenite. Thromb Res 105(1): 55-62.
37. Joannides R, Bellien J, Thuillez C (2006) Clinical methods for the evaluation of endothelial function-a focus on resistance arteries. Fundam Clin Pharmacol 20(3): 311-320. doi: 10. 1111/j. 1472-8206. 2006. 00406. x.
38. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M (2011) Arsenic: toxicity, oxidative stress, and human disease. J Appl Toxicol 31(2): 95-107. doi: 10. 1002/jat. 1649.
39. Jovanovic D, Rasic-Milutinovic Z, Paunovic K, Jakovljevic B, Plavsic S, Milosevic J (2012) Low levels of arsenic in drinking water and type 2 diabetes in Middle Banat region, Serbia. Int J Hyg Environ Health. doi: 10. 1016/j. ijheh. 2012. 01. 001.
40. Kim Y, Lee BK (2011) Association between urinary arsenic and diabetes mellitus in the Korean general population according to KNHANES 2008. Sci Total Environ 409(19): 4054-4062. doi: 10. 1016/j. scitotenv. 2011. 06. 003.
41. Lee MY, Bae ON, Chung SM, Kang KT, Lee JY, Chung JH (2002) Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: A contributing factor to cardiovascular disease. Toxicol Appl Pharmacol 179(2): 83-88. doi: 10. 1006/taap. 2001. 9356.
42. Lee MY, Jung BI, Chung SM, Bae ON, Lee JY, Park JD, Yang JS, Lee H, Chung JH (2003) Arsenic-induced dysfunction in relaxation of blood vessels. Environ Health Perspect 111(4): 513-517.
43. Lee MY, Lee YH, Lim KM, Chung SM, Bae ON, Kim H, Lee CR, Park JD, Chung JH (2005) Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ Health Perspect 113(10): 1330-1335.
44. Lemaire M, Lemarie CA, Molina MF, Schiffrin EL, Lehoux S, Mann KK (2011) Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model. Toxicol Sci 122(1): 211-221. doi: 10. 1093/toxsci/kfr097.
45. Li B, Sun Y, Sun X, Wang Y, Li X, Kumagai Y, Sun G (2007) Monomethylarsonous acid-induced cytotoxicity and endothelial nitric oxide synthase phosphorylation in endothelial cells. Bull Environ Contam Toxicol 78(6): 455-458. doi: 10. 1007/s00128-007-9178-7.
46. Li JX, Shen YQ, Cai BZ, Zhao J, Bai X, Lu YJ, Li XQ (2010) Arsenic trioxide induces the apoptosis in vascular smooth muscle cells via increasing intracellular calcium and ROS formation. Mol Biol Rep 37(3): 1569-1576. doi: 10. 1007/s11033-009-9561-z.
47. Lim KM, Shin YS, Kang S, Noh JY, Kim K, Chung SM, Yun YP, Chung JH (2011) Potentiation of vasoconstriction and pressor response by low concentration of monomethylarsonous acid (MMA(III)). Toxicol Lett 205(3): 250-256. doi: 10. 1016/j. toxlet. 2011. 06. 008.
48. Lin KH, Chang YF, Fan CY, Jayakumar T, Lee JJ, Chou DS, Hsiao G, Sheu JR (2010) Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade. Transl Res 155(2): 97-108. doi: 10. 1016/j. trsl. 2009. 08. 005.
49. Lisabeth LD, Ahn HJ, Chen JJ, Sealy-Jefferson S, Burke JF, Meliker JR (2010) Arsenic in drinking water and stroke hospitalizations in Michigan. Stroke 41(11): 2499-2504. doi: 10. 1161/STROKEAHA. 110. 585281.
50. Longo DL FA, Kasper D, Hauser S, Jameson JL, Loscalzo J (2012) Harrison's Principles of Internal Medicine. 17th edn. McGraw-Hill.
51. Luong MW, Rabkin SW (2009) Verapamil but not calpain or creatine alters arsenate-induced cardiac cell death. Toxicol Ind Health 25(3): 169-176. doi: 10. 1177/0748233709105593.
52. Marchiset-Ferlay N, Savanovitch C, Sauvant-Rochat MP (2012) What is the best biomarker to assess arsenic exposure via drinking water? Environ Int 39(1): 150-171. doi: 10. 1016/j. envint. 2011. 07. 015.
53. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, Silbergeld EK, Styblo M, Tseng CH, Thayer KA, Loomis D (2012) Evaluation of the association between arsenic and diabetes: A national toxicology program workshop review. Environ Health Perspect. doi: 10. 1289/ehp. 1104579.
54. Medrano MA, Boix R, Pastor-Barriuso R, Palau M, Damian J, Ramis R, Del Barrio JL, Navas-Acien A (2010) Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res 110(5): 448-454. doi: 10. 1016/j. envres. 2009. 10. 002.
55. Moon K, Guallar E, Navas-Acien A (2012) Arsenic exposure and cardiovascular disease: An updated systematic review. Curr Atheroscler Rep. doi: 10. 1007/s11883-012-0280-x.
56. Mordukhovich I, Wright RO, Amarasiriwardena C, Baja E, Baccarelli A, Suh H, Sparrow D, Vokonas P, Schwartz J (2009) Association between low-level environmental arsenic exposure and QT interval duration in a general population study. Am J Epidemiol 170(6): 739-746. doi: 10. 1093/aje/kwp191.
57. Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, Sanders WE (2007) Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect 115(5): 690-694. doi: 10. 1289/ehp. 9686.
58. Navas-Acien A, Sharrett AR, Guallar E (2006) Three authors reply. Am J Epidemiol 164(2): 195-196. doi: 10. 1093/aje/kwj198.
59. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E (2008) Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300(7): 814-822. doi: 10. 1001/jama. 300. 7. 814.
60. Owlya R, Vollenweider L, Trueb L, Sartori C, Lepori M, Nicod P, Scherrer U (1997) Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation 96(11): 3897-3903.
61. Patel SP, Garcia-Manero G, Ferrajoli A, Faderl S, Verstovek S, Kantarjian H, Estey E (2006) Cardiotoxicity in African-American patients treated with arsenic trioxide for acute promyelocytic leukemia. Leuk Res 30(3): 362-363. doi: 10. 1016/j. leukres. 2005. 08. 002.
62. Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H, Endo A, Yu L, Yuki K, Miyauchi T, Shimojo N (2000) Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 28(7): 1137-1142.
63. Roman DA, Pizarro I, Rivera L, Camara C, Palacios MA, Gomez MM, Solar C (2011) An approach to the arsenic status in cardiovascular tissues of patients with coronary heart disease. Hum Exp Toxicol 30(9): 1150-1164. doi: 10. 1177/0960327110389835.
64. Saposnik G (2010) Drinking water and risk of stroke: the hidden element. Stroke 41(11): 2451-2452. doi: 10. 1161/STROKEAHA. 110. 596395.
65. Shi H, Shi X, Liu KJ (2004) Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 255(1-2): 67-78.
66. Slotnick MJ, Nriagu JO (2006) Validity of human nails as a biomarker of arsenic and selenium exposure: A review. Environ Res 102(1): 125-139. doi: 10. 1016/j. envres. 2005. 12. 001.
67. Smith KR, Klei LR, Barchowsky A (2001) Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 280(3): L442-L449.
68. Srivastava S, Vladykovskaya EN, Haberzettl P, Sithu SD, D'Souza SE, States JC (2009) Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice. Toxicol Appl Pharmacol 241(1): 90-100. doi: 10. 1016/j. taap. 2009. 08. 004.
69. States JC, Srivastava S, Chen Y, Barchowsky A (2009) Arsenic and cardiovascular disease. Toxicol Sci 107(2): 312-323. doi: 10. 1093/toxsci/kfn236.
70. Suriyo T, Watcharasit P, Thiantanawat A, Satayavivad J (2012) Arsenite promotes apoptosis and dysfunction in microvascular endothelial cells via an alteration of intracellular calcium homeostasis. Toxicol In Vitro 26(3): 386-395. doi: 10. 1016/j. tiv. 2011. 12. 017.
71. Tseng WP (1977) Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 19: 109-119.
72. Tsou TC, Tsai FY, Hsieh YW, Li LA, Yeh SC, Chang LW (2005) Arsenite induces endothelial cytotoxicity by downregulation of vascular endothelial nitric oxide synthase. Toxicol Appl Pharmacol 208(3): 277-284. doi: 10. 1016/j. taap. 2005. 03. 001.
73. Vahter M (2000) Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112-113: 209-217.
74. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, Chiou HY, Wu MM, Chen CJ (2002) Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105(15): 1804-1809.
75. Wang CH, Chen CL, Hsiao CK, Chiang FT, Hsu LI, Chiou HY, Hsueh YM, Wu MM, Chen CJ (2009) Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan. Toxicol Appl Pharmacol 239(3): 320-324. doi: 10. 1016/j. taap. 2009. 06. 017.
76. Wang CH, Chen CL, Hsiao CK, Chiang FT, Hsu LI, Chiou HY, Hsueh YM, Wu MM, Chen CJ (2010) Arsenic-induced QT dispersion is associated with atherosclerotic diseases and predicts long-term cardiovascular mortality in subjects with previous exposure to arsenic: A 17-year follow-up study. Cardiovasc Toxicol 10(1): 17-26. doi: 10. 1007/s12012-009-9059-x.
77. Wang SL, Li WF, Chen CJ, Huang YL, Chen JW, Chang KH, Tsai LY, Chou KM (2011) Hypertension incidence after tap-water implementation: A 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan. Sci Total Environ 409(21): 4528-4535. doi: 10. 1016/j. scitotenv. 2011. 07. 058.
78. Watanabe T, Hirano S (2012) Metabolism of arsenic and its toxicological relevance. Arch Toxicol. doi: 10. 1007/s00204-012-0904-5.
79. WHO-IARC (2012) Arsenic and inorganic arsenic compounds. IARC Monographs 100C.
80. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, Bates MN, Smith AH (2007) Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 166(12): 1381-1391. doi: 10. 1093/aje/kwm238.
81. Zhang C, Mao G, He S, Yang Z, Yang W, Zhang X, Qiu W, Ta N, Cao L, Yang H, Guo X (2012a) Relationship between long-term exposure to low-level arsenic in drinking water and the prevalence of abnormal blood pressure. J Hazard Mater. doi: 10. 1016/j. jhazmat. 2012. 09. 045.
82. Zhang W, Xue J, Ge M, Yu M, Liu L, Zhang Z (2012b) Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide. Food Chem Toxicol 51C: 87-92. doi: 10. 1016/j. fct. 2012. 09. 023.
83. Zhao X, Feng T, Chen H, Shan H, Zhang Y, Lu Y, Yang B (2008a) Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin Pharmacol Toxicol 102(5): 419-425. doi: 10. 1111/j. 1742-7843. 2007. 00150. x.
84. Zhao XY, Li GY, Liu Y, Chai LM, Chen JX, Zhang Y, Du ZM, Lu YJ, Yang BF (2008b) Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol 154(1): 105-113. doi: 10. 1038/bjp. 2008. 81.
85. Zierold KM, Knobeloch L, Anderson H (2004) Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health 94(11): 1936-1937.